This snapshot, taken on
13/05/2013
, shows web content acquired for preservation by The National Archives. External links, forms and search may not work in archived websites and contact details are likely to be out of date.
 
 
The UK Government Web Archive does not use cookies but some may be left in your browser from archived websites.

Proposed merger of Southern Health NHS Foundation Trust with Oxfordshire Learning Disability NHS Trust

Southern Health NHS Foundation Trust and Oxfordshire Learning Disability NHS Trust are proposing to merge.

Consistent with its merger guidelines, the CCP will examine the costs and benefits of the proposed merger of these mental health trusts to patients and taxpayers, in order to ascertain whether the transaction is consistent with Principle 10 of the Principles and Rules for Cooperation and Competition. In doing so, the CCP will consider the effect of the transaction on patient choice and competition for mental health and community services in the PCT areas of Buckinghamshire, Oxfordshire, Wiltshire, Dorset, Hampshire, the Isle of Wight and any other relevant surrounding areas.

The CCP welcomes submissions in writing from interested individuals and organisations on this issue or any other matter relevant to the CCP's assessment of this transaction under the Principles and Rules for Cooperation and Competition. To submit evidence please use the email address: cases@ccpanel.gsi.gov.uk.

The closing date for initial submissions is 6 July 2012.

Administrative timetable

Event Date
CCP publishes Notice of Acceptance 15 June 2012
Closing date for Phase I submissions 6 July 2012
Deadline for completion of Phase I *10 August 2012
Deadline for completion of Phase II (if required) **3 December 2012

* At the end of Phase I, the CCP will either:

  • recommend that the merger be allowed to proceed, or
  • recommend that the merger be allowed to proceed subject to measures agreed with the parties that address concerns identified by the CCP during Phase I, or
  • proceed to a more detailed Phase II investigation.

** Phase II allows the CCP to conduct a more in-depth investigation where this is required to fully assess a merger.

NB. This timetable will be updated as required during the course of the inquiry.


Department of Health NHS Monitor